CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE

Published:2015-09 Issue:9 Volume:35 Page:1743-1749
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Souied Eric H.,Oubraham Hassiba,Mimoun Gérard,Cohen Salomon Y.,Quere Stéphane,Derveloy Audrey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference11 articles.

1. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.;Holmes;Cell Signal,2010

2. . Ranibizumab for neovascular age-related macular degeneration.;Rosenfeld;N Engl J Med,2006

3. . Ranibizumab versus verteporfin for neovascular age-related macular degeneration.;Brown;N Engl J Med,2006

4. A review of ranibizumab clinical trial data in exudative age-related macular degeneration and how to translate it into daily practice.;Mones;Ophthalmologica,2011

5. . Combined ranibizumab and photodynamic therapy to treat exudative age-related macular degeneration. An option for improving treatment efficiency.;Mataix;Retina,2010

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Tolerability of Suprachoroidal Axitinib, CLS-AX, for Neovascular AMD; Phase 1/2a Open-Label, Dose-Escalation Trial;Ophthalmology Science;2024-07

2. Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions;Pharmaceutics;2024-02-23

3. Aflibercept monotherapy or bevacizumab first for diabetic macular edema;Indian Journal of Ophthalmology;2024-01-25

4. Results of anti-VEGF treatment for neovascular AMD in eyes with different baseline visual acuity in Turkish population-based on real life data-Bosphorus retina study group;Photodiagnosis and Photodynamic Therapy;2023-06

5. Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3